top of page

Using a cell therapy as a potential treatment for Parkinson’s with BlueRock's CEO

CEO Seth Ettenberg explains how BlueRock is using pluripotent stems cells to try to restore dopamine production in Parkinson’s patients.



Comments


Join the BiotechTV mailing list

Thanks for subscribing!

bottom of page